Table 5.

Association between initial stroke severity and 3 months outcome by LDL-C levels and pre-ICH lipid-lowering drugs use in TSR.

	OR (95% CI)
All ICH patients (n = 4,606)	Crude	Age/sex-adjusted	Multivariate adjusted
3-month mortality
<100	1.39 (0.91, 2.11)	1.35 (0.88, 2.05)	1.84 (1.28, 2.63)
<70	1.82 (1.36, 2.42)	1.75 (1.31, 2.34)	1.33 (0.79, 2.23)
70–99	1.13 (0.71, 1.80)	1.10 (0.69, 1.76)	1.21 (0.68, 2.14)
100–109	0.74 (0.38, 1.45)	0.74 (0.38, 1.44)	0.71 (0.31,1.63)
110–129	1	1	1
130–159	0.43 (0.21, 0.88)	0.42 (0.20, 0.87)	0.38 (0.15,0.95)
160–179	0.62 (0.21, 1.81)	0.64 (0.22, 1.89)	0.57 (0.13,2.55)
≥180	0.94 (0.32, 2.80)	1.04 (0.35, 3.08)	1.15 (0.32, 4.14)
Pre-ICH lipid-lowering drugs use	0.74 (0.41, 1.34)	0.70 (0.38, 1.29)	0.84 (0.43,1.66)
3-month mRS >2
<100	1.04 (0.90, 1.20)	0.97 (0.84, 1.13)	0.96 (0.81, 1.13)
<70	1.02 (0.81, 1.28)	0.97 (0.77, 1.22)	0.98 (0.75, 1.29)
70–99	1.30 (1.00, 1.68)	1.26 (0.97, 1.64)	1.27 (0.94, 1.73)
100–109	1.26 (0.90, 1.77)	1.26 (0.89, 1.77)	1.37 (0.92, 2.04)
110–129	1	1
130–159	0.93 (0.69, 1.26)	0.95 (0.70, 1.29)	1
160–179	1.12 (0.68, 1.82)	1.24 (0.76, 2.04)	1.01 (0.71, 1.44)
≥180	1.01 (0.57, 1.79)	1.21 (0.68, 2.16)	1.24 (0.70, 2.19)
Pre-ICH lipid-lowering drugs use	0.94 (0.70, 1.27)	0.85 (0.63, 1.16)	1.03 (0.54, 1.97)
Initial NIHSS score >15
<100	1.36 (1.06, 1.75)	1.35 (1.05, 1.73)	1.35 (1.13, 1.62)
<70	1.65 (1.26, 2.16)	1.64 (1.25, 2.15)	1.53 (1.12, 2.09)
70–99	1.34 (1.16, 1.56)	1.32 (1.14, 1.54)	1.99 (1.42, 2.79)
100–109	1.15 (0.80, 1.64)	1.15 (0.80, 1.63)	1.20 (0.78, 1.86)
110–129	1	1	1
130–159	1.05 (0.75, 1.47)	1.06 (0.76, 1.48)	1.38 (0.93, 2.06)
160–179	1.24 (0.74, 2.05)	1.26 (0.76, 1.48)	1.61 (0.86, 3.00)
≥180	1.02 (0.55, 1.90)	1.06 (0.57, 1.98)	1.17 (0.56, 2.46)
Pre-ICH lipid-lowering drugs use	0.87 (0.63, 1.20)	0.85 (0.61, 1.16)	0.95 (0.65, 1.38)